They indicated the potential mechanisms might be that PCSK9 promoted lysosomal degradation by physically binding to MHC-I, disrupting the recirculation of MHC-I to the tumor cell surface and thus reducing cell surface MHC-I signaling [55] (Fig. 3). The gene discussed is PCSK9; the disease is neoplasm.